Perpetua Medical AB (P75)

Overview

Perpetua Medical AB (publ), once known as Pharmacolog i Uppsala AB (publ), rebranded itself in April 2024 to better reflect its evolving focus and offerings in the healthcare technology sector. Established in 2007 and headquartered in Uppsala, Sweden, the company specializes in developing innovative products and solutions aimed at enhancing the safety and efficiency of injectable drug use. It primarily serves the Swedish healthcare market, emphasizing the reduction of medication errors and the improvement of drug handling processes in pharmacies and healthcare facilities. Perpetua Medical AB (publ) operates under the ownership of Nolsterby Invest AB, indicating a strategic alignment with broader business interests in the healthcare and technology arenas.

Products and Services

• DrugLog:

This pioneering solution targets the critical issue of medication errors in pharmacies by offering a technology-driven approach to verify the correctness of injectable drugs before administration to patients. The relevance of such a system lies in its potential to significantly lower the risk of preventable adverse drug events, enhancing patient safety and healthcare outcomes.

• WasteLog:

WasteLog is an innovative device designed to analyze the waste and returns of injectable controlled substances. Its primary function is to ensure that drugs are disposed of or recycled in an environmentally safe and regulatory-compliant manner, while also offering healthcare facilities a tool to monitor and manage drug waste effectively, mitigating potential abuse or diversion of controlled substances.

• PrepLog:

Built on the foundation of DrugLog technology, PrepLog extends its capabilities to integrate with prescription software or medication management systems, facilitating the testing of drug preparations. This platform embodies the next step in pharmacy digitization, aiming to streamline workflow, reduce human error, and increase the accuracy of drug dispensation processes in healthcare settings.